These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11507236

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Induction of tumours by administration of N-dibutylnitrosamine and derivatives to infant mice.
    Fujii K, Odashima S, Okada M.
    Br J Cancer; 1977 May; 35(5):610-4. PubMed ID: 861148
    [Abstract] [Full Text] [Related]

  • 23. The effect of disulfiram on the carcinogenicity of N-butyl-N-(3-carboxypropyl)nitrosamine in the rat.
    Irving CC, Daniel DS, Murphy WM.
    Carcinogenesis; 1983 May; 4(5):617-20. PubMed ID: 6850994
    [Abstract] [Full Text] [Related]

  • 24. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A, Ogawa K, Sugiura S, Asamoto M, Takeshita F, Sato SY, Nakanishi M, Kohri K, Shirai T.
    Int J Cancer; 2008 Mar 15; 122(6):1222-8. PubMed ID: 18027869
    [Abstract] [Full Text] [Related]

  • 25. Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice.
    Wei M, Wanibuchi H, Morimura K, Salim EI, Moku M, Doi K, Mitsuhashi M, Masuda C, Shen J, Kinoshita A, Fukushima S.
    Anticancer Res; 2004 Mar 15; 24(2B):785-90. PubMed ID: 15161027
    [Abstract] [Full Text] [Related]

  • 26. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Masui T, Dong Y, Yamamoto S, Takada N, Nakanishi H, Inada K, Fukushima S, Tatematsu M.
    Cancer Lett; 1996 Jul 19; 105(1):105-12. PubMed ID: 8689624
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S, Min W, Lee CC, Salim EI, Wanibuchi H, Sukata T, Fukushima S.
    Cancer Lett; 1999 Jan 29; 135(2):137-44. PubMed ID: 10096421
    [Abstract] [Full Text] [Related]

  • 28. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
    Iida K, Itoh K, Maher JM, Kumagai Y, Oyasu R, Mori Y, Shimazui T, Akaza H, Yamamoto M.
    Carcinogenesis; 2007 Nov 29; 28(11):2398-403. PubMed ID: 17602169
    [Abstract] [Full Text] [Related]

  • 29. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB.
    Mutat Res; 2012 Feb 18; 742(1-2):92-5. PubMed ID: 22155125
    [Abstract] [Full Text] [Related]

  • 30. Gut microbiome and bladder cancer: A new link through nitrosamine metabolism.
    Mani S.
    Cell Host Microbe; 2024 Oct 09; 32(10):1637-1639. PubMed ID: 39389023
    [Abstract] [Full Text] [Related]

  • 31. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
    Hong JY, Wang YY, Mohr SN, Bondoc FY, Deng C.
    Res Rep Health Eff Inst; 2001 May 09; (102):7-27; discussion 95-109. PubMed ID: 11504148
    [Abstract] [Full Text] [Related]

  • 32. Concanavalin A agglutination of bladder cells of rats treated with bladder carcinogens; a rapid new test to detect bladder carcinogens.
    Kakizoe T, Kawachi T, Okada M.
    Cancer Lett; 1978 Nov 09; 5(5):285-90. PubMed ID: 728886
    [Abstract] [Full Text] [Related]

  • 33. Bladder carcinogenesis in mice induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and N-ethyl-N-(4-hydroxybutyl)-nitrosamine with reference to the effect of cyclophosphamide.
    Numoto S, Yoshida M, Otsuka H.
    Gan; 1981 Oct 09; 72(5):647-54. PubMed ID: 7327366
    [Abstract] [Full Text] [Related]

  • 34. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K, Yamamoto S, Murai T, Mori S, Chen TX, Wanibuchi H, Fukushima S.
    Carcinogenesis; 1999 Apr 09; 20(4):715-8. PubMed ID: 10223204
    [Abstract] [Full Text] [Related]

  • 35. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B, Sivakumar A, Balakrishnan D, Sundaresan S.
    J Exp Ther Oncol; 2017 Sep 09; 11(2):139-416. PubMed ID: 28976137
    [Abstract] [Full Text] [Related]

  • 36. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
    Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T.
    Carcinogenesis; 1992 Oct 09; 13(10):1789-94. PubMed ID: 1423839
    [Abstract] [Full Text] [Related]

  • 37. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases.
    Lin DX, Malaveille C, Park SS, Gelboin HV, Bartsch H.
    Carcinogenesis; 1990 Sep 09; 11(9):1653-8. PubMed ID: 2119260
    [Abstract] [Full Text] [Related]

  • 38. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M.
    Cancer Res; 2004 Sep 15; 64(18):6424-31. PubMed ID: 15374950
    [Abstract] [Full Text] [Related]

  • 39. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E, Iiyoshi M, Okada M.
    Gan; 1981 Feb 15; 72(1):113-22. PubMed ID: 7274637
    [Abstract] [Full Text] [Related]

  • 40. A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats.
    Yamamoto K, Nakata D, Tada M, Tonoki H, Nishida T, Hirai A, Ba Y, Aoyama T, Hamada J, Furuuchi K, Harada H, Hirai K, Shibahara N, Katsuoka Y, Moriuchi T.
    Int J Cancer; 1999 Nov 26; 83(5):700-5. PubMed ID: 10521810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.